We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,057

General Court of the EU Confirms Fines Imposed on Lundbeck and Generic Drug Manufacturers for Entering into Patent Settlements
  • McDermott Will & Emery
  • European Union
  • September 22 2016

On 8 September 2016, the General Court of the EU (GCEU) handed down five judgments upholding a decision by the Commission of 19 June 2013 imposing

How the impending Brexit impacts the legal framework of doing business with the UK- the German perspective
  • Heuking Kühn Lüer Wojtek
  • European Union, Germany, United Kingdom
  • September 20 2016

In a referendum, held in the United Kingdom on June 23, 2016, a majority of voters decided in favor of the United Kingdom of Great Britain and

EU & Competition Law Review 14 September 2016
  • Roschier
  • European Union, Finland
  • September 14 2016

On 8 September 2016, the General Court ("GC") gave six judgments dismissing appeals by Lundbeck, a Danish pharmaceutical company, and several generic

"Pay for Delay" Agreements infringe EU Competition Law: European General Court
  • Bird & Bird
  • European Union
  • September 13 2016

The European General Court has issued a judgment confirming that "pay for delay" agreements in the pharmaceuticals sector constitute serious

EU General Court upholds Commission decision in its first "pay-for-delay" case
  • Herbert Smith Freehills LLP
  • European Union
  • September 9 2016

On 8 September 2016 the General Court (GC) handed down its judgments in relation to the appeals brought by Lundbeck and a number of generic companies

Breaking news - General Court confirms Lundbeck decision and fine
  • Bristows LLP
  • European Union
  • September 8 2016

The General Court of the EU has upheld the European Commission decision fining Lundbeck and a number of generic companies in relation to patent

Implications of the UK’s Brexit Referendum
  • Ropes & Gray LLP
  • European Union, Global, OECD, United Kingdom, USA
  • September 1 2016

Potential implications on the use of passporting for asset management firms in a post-Brexit world Following the “Leave” result of the United

After Brexit
  • Clifford Chance LLP
  • European Union, United Kingdom
  • August 24 2016

On 23 June 2016, the UK population voted to leave the European Union, with 52 of the more than 32 million people that voted opting for Brexit. What

Brussels GA&P (July 2016)
  • Gómez-Acebo & Pombo Abogados
  • European Union, Spain
  • August 5 2016

Up to March 2015 ATM owners and banks issuing credit cards (issuing banks) had an agreement where they approved the right to use each others ATMs at a

La obligación contractual de pagar un canon por la utilización de una tecnología después de haber sido declarada nula la patente que la protegía no es una práctica colusoria
  • Gómez-Acebo & Pombo Abogados
  • European Union
  • August 5 2016

Uno de los problemas recurrentes en los contratos de licencia de patente (y deotros derechos de propiedad industrial) es el de determinar qué sucede